Enrique Carrazana, MD

  • 3Articles
  • 32.3KReads1
  • 2021–2025Active
  • 12Collaborators
  • 5Citations2

About

Enrique Carrazana, MD, is affiliated with Clinical Development and Medical Affairs at Neurelis Inc in San Diego, California, and the John A. Burns School of Medicine at the University of Hawaii in Honolulu. Dr. Carrazana has published research from 2021 to 2025 on topics including bipolar disorder, schizophrenia and schizoaffective disorders, complementary and alternative medicine, and COVID-19. His work includes studies on pharmacokinetics of olanzapine formulations, alternative treatments for acute agitation in psychiatric conditions, and the impact of anxiety sensitivity on COVID-19 recovery. He has frequently collaborated with Adrian L. Rabinowicz, Christoph U. Correll, Leslie Citrome, Miguel Lopez-Toledano, and Stuart Madden.

Publications

JCP
Pharmacokinetics of Olanzapine Intranasal Spray vs Olanzapine IM
PCC
Alternative Treatment for Agitation in Schizophrenia and Bipolar Disorder
PCC

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.